Cargando…
Genomics, Other “Omic” Technologies, Personalized Medicine, and Additional Biotechnology-Related Techniques
The products resulting for biotechnologies continue to grow at an exponential rate, and the expectations are that an even greater percentage of drug development will be in the area of the biologics. In 2011, worldwide there were over 800 new biotech drugs and treatments in development including 23 a...
Autor principal: | Sindelar, Robert D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122419/ http://dx.doi.org/10.1007/978-1-4614-6486-0_8 |
Ejemplares similares
-
Personal genomes, quantitative dynamic omics and personalized medicine
por: Mias, George I., et al.
Publicado: (2013) -
Sepsis: Personalized Medicine Utilizing ‘Omic’ Technologies—A Paradigm Shift?
por: Itenov, Theis Skovsgaard, et al.
Publicado: (2018) -
Editorial: Using Genomics, Metagenomics and Other “Omics” to Assess Valuable Microbial Ecosystem Services and Novel Biotechnological Applications
por: Marco, Diana E., et al.
Publicado: (2019) -
Omics-Driven Biotechnology for Industrial Applications
por: Amer, Bashar, et al.
Publicado: (2021) -
Editorial: Environmental omics and their biotechnological applications
por: Martínez-Espinosa, Rosa María, et al.
Publicado: (2023)